BioCentury
ARTICLE | Finance

Larger stakes, more newcos as Canaan moves to bump up biopharma investments with new $800M fund

Canaan plans to ramp up biopharma company formation out of its twelfth fund

October 15, 2020 1:02 AM UTC

With 40% of its new $800 million fund dedicated to healthcare, Canaan plans to ramp up biopharma investments and de novo company formation as it seeks larger ownership stakes. “Given the ...



Access this Article